|
61 |
Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics
Enthalten in Acta neuropathologica Bd. 146, 30.9.2023, Nr. 6, date:12.2023: 853-856
|
|
|
|
62 |
Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1
Enthalten in Acta neuropathologica Bd. 142, 19.4.2021, Nr. 1, date:7.2021: 179-189
|
|
|
|
63 |
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions
Enthalten in Acta neuropathologica Bd. 145, 18.3.2023, Nr. 5, date:5.2023: 667-680
|
|
|
|
64 |
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types
Enthalten in Acta neuropathologica Bd. 142, 18.9.2021, Nr. 6, date:12.2021: 1065-1069
|
|
|
|
65 |
How to use and assess qualitative research methods
Enthalten in Neurological research and practice Bd. 2, 27.5.2020, Nr. 1, date:12.2020: 1-10
|
|
|
|
66 |
“I didn’t even wonder why I was on the floor” – mixed methods exploration of stroke awareness and help-seeking behaviour at stroke symptom onset
Enthalten in BMC health services research Bd. 24, 2.8.2024, Nr. 1, date:12.2024: 1-12
|
|
|
|
67 |
Identification of a putative molecular subtype of adult-type diffuse astrocytoma with recurrent MAPK pathway alterations
Enthalten in Acta neuropathologica Bd. 148, 18.7.2024, Nr. 1, date:12.2024: 1-5
|
|
|
|
68 |
IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spread
Enthalten in Acta neuropathologica Bd. 149, 3.2.2025, Nr. 1, date:6.2025: 1-13
|
|
|
|
69 |
Impact of 18F-FET PET on Target Volume Definition and Tumor Progression of Recurrent High Grade Glioma Treated with Carbon-Ion Radiotherapy
Enthalten in Scientific reports Bd. 8, 8.5.2018, Nr. 1, date:12.2018: 1-13
|
|
|
|
70 |
Impact of delays in initiating postoperative chemoradiation while determining the MGMT promoter-methylation statuses of patients with primary glioblastoma
Enthalten in BMC cancer Bd. 15, 30.7.2015, Nr. 1, date:12.2015: 1-7
|
|
Administration
